Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Frances Mair and Bhautesh Jani.
Frances Mair
Connection Strength
2.599
Bhautesh Jani
  1. Recording COVID-19 consultations: review of symptoms, risk factors, and proposed SNOMED CT terms. BJGP Open. 2020 Oct; 4(4).
    View in: PubMed
    Score: 0.910
  2. Relationship of depression screening in cardiometabolic disease with vascular events and mortality: findings from a large primary care cohort with 4 years follow-up. Eur Heart J Qual Care Clin Outcomes. 2017 01 01; 3(1):61-73.
    View in: PubMed
    Score: 0.698
  3. Comparison of COVID-19 outcomes among shielded and non-shielded populations. Sci Rep. 2021 07 27; 11(1):15278.
    View in: PubMed
    Score: 0.240
  4. Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants. Lancet Public Health. 2018 07; 3(7):e323-e332.
    View in: PubMed
    Score: 0.193
  5. Correction: Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort. PLoS One. 2021; 16(5):e0251613.
    View in: PubMed
    Score: 0.059
  6. Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants. Occup Environ Med. 2020 Dec 09.
    View in: PubMed
    Score: 0.057
  7. COVID-19 Surveillance in a Primary Care Sentinel Network: In-Pandemic Development of an Application Ontology. JMIR Public Health Surveill. 2020 11 17; 6(4):e21434.
    View in: PubMed
    Score: 0.057
  8. Comparison of two different frailty measurements and risk of hospitalisation or death from COVID-19: findings from UK Biobank. BMC Med. 2020 11 10; 18(1):355.
    View in: PubMed
    Score: 0.057
  9. Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants. PLoS One. 2020; 15(11):e0241824.
    View in: PubMed
    Score: 0.057
  10. Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort. PLoS One. 2020; 15(8):e0238091.
    View in: PubMed
    Score: 0.056
  11. Corrigendum to "Vitamin D concentrations and COVID-19 infection in UK Biobank" [Diabetes Metabol Syndr: Clin Res Rev 2020 14 (4) 561-5]. Diabetes Metab Syndr. 2020 Sep - Oct; 14(5):1315-1316.
    View in: PubMed
    Score: 0.056
  12. Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank. BMC Med. 2020 05 29; 18(1):160.
    View in: PubMed
    Score: 0.055
  13. Vitamin D concentrations and COVID-19 infection in UK Biobank. Diabetes Metab Syndr. 2020 Jul - Aug; 14(4):561-565.
    View in: PubMed
    Score: 0.055
  14. Impact of multimorbidity count on all-cause mortality and glycaemic outcomes in people with type 2 diabetes: a systematic review protocol. BMJ Open. 2018 04 05; 8(4):e021100.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.